Coromandel slips 6% after block deals; EID Parry hits 52-week high

Around 6.51 million equity shares, representing 2.2 per cent of total equity of Coromandel International, changed hands via block deal on the BSE at open

Topics
Buzzing stocks | Markets | Coromandel International EID Parry

SI Reporter  |  Mumbai 

Shares of slipped 6 per cent to Rs 802 on the BSE on Wednesday after more than 2 per cent stake of the fertilser company changed hands in opening deals.

At 09:15 am, around 6.51 million equity shares, representing 2.2 per cent of total equity of Coromandel International, had changed hands via block deal on the BSE, the exchange data shows. The names of the buyers and sellers were not ascertained immediately. The stock of hit a record high of Rs 880 on Tuesday, December 29, on the BSE.

Earlier, in June 2, Coromandel International’s holding company viz., E.I.D. - Parry (India) had sold 5.85 million equity shares held in the Company through open market at a price of Rs 629.91 per share. had said the proceeds of sale will be used to bring down the debt of the company.

Meanwhile, the stock of hit a 52-week high of Rs 365.75, rallying 10 per cent on the BSE in early morning trade in an otherwise range-bound market. At 09:29 am, the S&P BSE Sensex was down 0.19 per cent at 47,524 points.

Analysts at Emkay Global Financial Services have ‘buy’ rating on with target price of Rs 910 per share. “We continue to remain positive on the company’s long-term opportunity, we believe that the delay in subsidy payment by the government will lead to deterioration in working capital by 10 days,” the brokerage firm said in September quarter result update.

Coromandel International’s crop protection revenue increased 25 per cent yoy to Rs 640 crore on the back of new products launched in the last two years in the domestic market and strong demand across B2B channels (especially in Mancozeb and domestic formulation). EBIT (earnings before interest tax) margin increased by 540bps yoy to 21.7 per cent on the back of improved product mix and higher utilization of the Mancozeb plant. We expect EBIT margins to improve further in H2FY21 as well on the back of better product mix, it said.

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Read our full coverage on Buzzing stocks
First Published: Wed, December 30 2020. 09:38 IST
RECOMMENDED FOR YOU